This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Katie Gaynor, Ph.D.
Principal Scientist at Bicycle Therapeutics


Katie Gaynor is a Principal Scientist in the Core Phage Group in Discovery Biology at Bicycle Therapeutics. She oversees early-stage research projects across oncology, anti-viral, and neurology targets. Prior to joining Bicycle, Katie worked in antibody discovery and optimisation at Pfizer, as well as completing post-docs in oncology at the University of Oxford, and respiratory medicine at University College Dublin. She holds a Masters of Biochemistry and a DPhil in Clinical Medicine from the University of Oxford.

Agenda Sessions

  • The Power of Delivery when Oligonucleotides and Peptides Come Together: The Peptide Perspective